Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Change in Receivables (2022 - 2025)

Coeptis Therapeutics Holdings has reported Change in Receivables over the past 3 years, most recently at $52500.0 for Q3 2025.

  • Quarterly results put Change in Receivables at $52500.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $52500.0 (changed N/A YoY), and the annual figure for FY2023 was -$8075.0, down 200.0%.
  • Change in Receivables for Q3 2025 was $52500.0 at Coeptis Therapeutics Holdings, up from -$8075.0 in the prior quarter.
  • Over the last five years, Change in Receivables for COEPW hit a ceiling of $52500.0 in Q3 2025 and a floor of -$8075.0 in Q1 2023.
  • Median Change in Receivables over the past 3 years was $8075.0 (2022), compared with a mean of $17500.0.